Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality could help prevent eating disorders in At-Risk youth

NCT ID NCT07565129

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 6-week group program called PrevED MR that uses mixed reality and virtual reality to teach emotion regulation skills to teens and young adults at risk for eating disorders. The program includes 12 sessions combining therapy exercises with immersive experiences. Researchers will measure changes in eating disorder symptoms, body image acceptance, and emotion regulation in 72 participants randomly assigned to the program or a waiting list.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mixed reality based dialectical behavioral therapy
What this could lead to
If it works, this could point toward a new way to prevent eating disorders in at-risk youth by teaching emotion regulation skills through immersive technology.
What could go wrong
This is a small early feasibility study with only 72 participants, so results may not apply broadly. The intervention is behavioral and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents and young adults aged 13 to 35 years. * Spanish-speaking participants who are able to understand the study procedures and complete the assessment instruments. * Students recruited from participating schools, universities, or related recruitment settings. * Participants at mid-to-high risk of developing eating disorders, as assessed by the Eating Attitudes Test-26 (EAT-26) and selected subscales of the Eating Disorder Inventory-3 (EDI-3). * Participants who provide informed consent. For minors, informed consent from a parent or legal guardian will also be required, together with the minor's assent when applicable. Exclusion Criteria: * Current or past self-reported diagnosis of an eating disorder. * Current severe psychiatric symptoms or diagnosis that could interfere with participation, including suicidal, manic, or psychotic symptoms. * Severe neurodevelopmental disorder, intellectual disability, or other cognitive impairment that could interfere with understanding or completing the study procedures. * Physical, motor, or sensory impairment that could interfere with the assessment procedures or the use of the mixed/virtual reality intervention. * Current psychological or pharmacological treatment for a mental health disorder delivered on a weekly or biweekly basis. * Inability to understand Spanish. * Failure to provide informed consent. For minors, lack of parent or legal guardian consent will also be an exclusion criterion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eating disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emotional Regulation Feeding and Eating Disorders eating disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universitat Internacional de Catalunya

    RECRUITING

    Barcelona, Barcelona, 08017, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.